The transition zone as a host for recycled volatiles: Evidence from nitrogen and carbon isotopes in ultra-deep diamonds from Monastery and Jagersfontein (South Africa)

Sublithospheric (ultra-deep) diamonds provide a unique window into the deepest parts of Earth's mantle, which otherwise remain inaccessible. Here, we report the first combined C- and N-isotopic data for diamonds from the Monastery and Jagersfontein kimberlites that sample the deep asthenosphere and transition zone beneath the Kaapvaal Craton, in the mid Cretaceous, to investigate the nature of mantle fluids at these depths and the constraints they provide on the deep volatile cycle. Both diamond suites exhibit very light δ13C values (down to − 26‰) and heavy δ15N (up to + 10.3‰), with nitrogen abundances generally below 70 at. ppm but varying up to very high concentrations (2520 at. ppm) in rare cases. Combined, these signatures are consistent with derivation from subducted crustal materials. Both suites exhibit variable nitrogen aggregation states from 25 to 100% B defects. Internal growth structures, revealed in cathodoluminescence (CL) images, vary from faintly layered, through distinct cores to concentric growth patterns with intermittent evidence for dissolution and regular octahedral growth layers in places. Modelling the internal co-variations in δ13C-δ15N-N revealed that diamonds grew from diverse C-H-O-N fluids involving both oxidised and reduced carbon species. The diversity of the modelled diamond-forming fluids highlights the complexity of the volatile sources and the likely heterogeneity of the deep asthenosphere and transition zone. We propose that the Monastery and Jagersfontein diamonds form in subducted slabs, where carbon is converted into either oxidised or reduced species during fluid-aided dissolution of subducted carbon before being re-precipitated as diamond. The common occurrence of recycled C and N isotopic signatures in super-deep diamonds world-wide indicates that a significant amount of carbon and nitrogen is recycled back to the deep asthenosphere and transition zone via subducting slabs, and that the transition zone may be dominated by recycled C and N

What is the remaining status of adaptive servo-ventilation? The results of a real-life multicenter study (OTRLASV-study). Adaptive servo-ventilation in real-life conditions

Backgrounds: As a consequence of the increased mortality observed in the SERVE-HF study, many questions concerning the safety and rational use of ASV in other indications emerged. The aim of this study was to describe the clinical characteristics of ASV-treated patients in real-life conditions. Methods: The OTRLASV-study is a prospective, 5-centre study including patients who underwent ASV-treatment for at least 1 year. Patients were consecutively included in the study during the annual visit imposed for ASV- reimbursement renewal. Results: 177/214 patients were analysed (87.57% male) with a median (IQ25–75) age of 71 (65–77) years, an ASV- treatment duration of 2.88 (1.76–4.96) years, an ASV-usage of 6.52 (5.13–7.65) hours/day, and 54.8% were previously treated via continuous positive airway pressure (CPAP). The median Epworth Scale Score decreased from 10 (6–13.5) to 6 (3–9) (p < 0.001) with ASV-therapy, the apnea-hypopnea-index decreased from 50 (38–62)/h to a residual device index of 1.9 (0.7–3.8)/h (p < 0.001). The majority of patients were classified in a Central-Sleep-Apnea group (CSA; 59.3%), whereas the remaining are divided into an Obstructive-Sleep-Apnea group (OSA; 20.3%) and a Treatment-Emergent-Central-Sleep-Apnea group (TECSA; 20.3%). The Left Ventricular Ejection Fraction (LVEF) was > 45% in 92.7% of patients. Associated comorbidities/etiologies were cardiac in nature for 75.7% of patients (neurological for 12.4%, renal for 4.5%, opioid-treatment for 3.4%). 9.6% had idiopathic central-sleep-apnea. 6.2% of the patients were hospitalized the year preceding the study for cardiological reasons. In the 6 months preceding inclusion, night monitoring (i.e. polygraphy or oximetry during ASV usage) was performed in 34.4% of patients, 25.9% of whom required a subsequent setting change. According to multivariable, logistic regression, the variables that were independently associated with poor adherence (ASV-usage ≤4 h in duration) were TECSA group versus CSA group (p = 0.010), a higher Epworth score (p = 0.019) and lack of a night monitoring in the last 6 months (p < 0.05). Conclusions: In real-life conditions, ASV-treatment is often associated with high cardiac comorbidities and high compliance. Future research should assess how regular night monitoring may optimize devices settings and patient management

Genes for hereditary sensory and autonomic neuropathies: a genotype–phenotype correlation

Hereditary sensory and autonomic neuropathies (HSAN) are clinically and genetically heterogeneous disorders characterized by axonal atrophy and degeneration, exclusively or predominantly affecting the sensory and autonomic neurons. So far, disease-associated mutations have been identified in seven genes: two genes for autosomal dominant (SPTLC1 and RAB7) and five genes for autosomal recessive forms of HSAN (WNK1/HSN2, NTRK1, NGFB, CCT5 and IKBKAP). We performed a systematic mutation screening of the coding sequences of six of these genes on a cohort of 100 familial and isolated patients diagnosed with HSAN. In addition, we screened the functional candidate gene NGFR (p75/NTR) encoding the nerve growth factor receptor. We identified disease-causing mutations in SPTLC1, RAB7, WNK1/HSN2 and NTRK1 in 19 patients, of which three mutations have not previously been reported. The phenotypes associated with mutations in NTRK1 and WNK1/HSN2 typically consisted of congenital insensitivity to pain and anhidrosis, and early-onset ulcero-mutilating sensory neuropathy, respectively. RAB7 mutations were only found in patients with a Charcot-Marie-Tooth type 2B (CMT2B) phenotype, an axonal sensory-motor neuropathy with pronounced ulcero-mutilations. In SPTLC1, we detected a novel mutation (S331F) corresponding to a previously unknown severe and early-onset HSAN phenotype. No mutations were found in NGFB, CCT5 and NGFR. Overall disease-associated mutations were found in 19% of the studied patient group, suggesting that additional genes are associated with HSAN. Our genotype–phenotype correlation study broadens the spectrum of HSAN and provides additional insights for molecular and clinical diagnosis

Switch of noninvasive ventilation (NIV) to continuous positive airway pressure (CPAP) in patients with obesity hypoventilation syndrome: a pilot study

International audienceObesity is a major worldwide public health issue. The main respiratory complication stemming from obesity is obesity hypoventilation syndrome (OHS). Most of the OHS patients diagnosed during an exacerbation are treated with non invasive ventilation (NIV). Up to date, no prospective study has demonstrated in real life conditions the feasibility of a systematic protocoled switch of NIV to continuous positive airway pressure (CPAP), once stability is achieved

Pain acceptance and personal control in pain relief in two maternity care models: a cross-national comparison of Belgium and the Netherlands

<p>Abstract</p> <p>Background</p> <p>A cross-national comparison of Belgian and Dutch childbearing women allows us to gain insight into the relative importance of pain acceptance and personal control in pain relief in 2 maternity care models. Although Belgium and the Netherlands are neighbouring countries sharing the same language, political system and geography, they are characterised by a different organisation of health care, particularly in maternity care. In Belgium the medical risks of childbirth are emphasised but neutralised by a strong belief in the merits of the medical model. Labour pain is perceived as a needless inconvenience easily resolved by means of pain medication. In the Netherlands the midwifery model of care defines childbirth as a normal physiological process and family event. Labour pain is perceived as an ally in the birth process.</p> <p>Methods</p> <p>Women were invited to participate in the study by independent midwives and obstetricians during antenatal visits in 2004-2005. Two questionnaires were filled out by 611 women, one at 30 weeks of pregnancy and one within the first 2 weeks after childbirth either at home or in a hospital. However, only women having a hospital birth without obstetric intervention (N = 327) were included in this analysis. A logistic regression analysis has been performed.</p> <p>Results</p> <p>Labour pain acceptance and personal control in pain relief render pain medication use during labour less likely, especially if they occur together. Apart from this general result, we also find large country differences. Dutch women with a normal hospital birth are six times less likely to use pain medication during labour, compared to their Belgian counterparts. This country difference cannot be explained by labour pain acceptance, since - in contrast to our working hypothesis - Dutch and Belgian women giving birth in a hospital setting are characterised by a similar labour pain acceptance. Our findings suggest that personal control in pain relief can partially explain the country differences in coping with labour pain. For Dutch women we find that the use of pain medication is lowest if women experience control over the reception of pain medication and have a positive attitude towards labour pain. In Belgium however, not personal control over the use of pain relief predicts the use of pain medication, but negative attitudes towards labour.</p> <p>Conclusions</p> <p>Apart from individual level determinants, such as length of labour or pain acceptance, our findings suggest that the maternity care context is of major importance in the study of the management of labour pain. The pain medication use in Belgian hospital maternity care is high and is very sensitive to negative attitudes towards labour pain. In the Netherlands, on the contrary, pain medication use is already low. This can partially be explained by a low degree of personal control in pain relief, especially when co-occurring with positive pain attitudes.</p

Glimpses of biodiversity in the Kadalundi-Vallikunnu Community Reserve, the first Community Reserve of Kerala

Biodiversity is the mainstay of ecosystem services and functions and supports the livelihood of millions of people. Sustainable utilization and conservation of our rich biological diversity is a prerequisite for human survival. India is a megadiverse country and with only 2.4% of the world’s geographical area, it accounts for 7 to 8% of all recorded species. Our country is a signatory to various international instruments focussing on matters of biodiversity, including the Convention on Biological Diversity (CBD). The country has an obligation to protect our rich biological diversity and is one of the leaders in having established a comprehensive legal and institutional system to achieve the objectives of the CBD. Expansion of India’s Protected Area (PA) network, including ‘Conservation and Community Reserves’ is one of the important action points of the National Biodiversity Action Plan of our country. The Kadalundi-Vallikunnu Community Reserve which lies in the Malabar region is the first Community Reserve of Kerala and is known for its rich biological diversity. Endowed with dense mangrove forests and mudflats, the Community Reserve is an abode to a large number of avian fauna, including many migratory species. Fishing and ecotourism have been the mainstay of income generation for many local inhabitants of the Community Reserve. Considering the ecological significance, diversity of wetland avian fauna and the burden of heavy anthropogenic pressures, the Kadalundi estuary was officially declared as the ‘Kadalundi-Vallikunnu Community Reserve’ in October, 2007. Bio-inventorying and documentation of biodiversity is invaluable for the wise use of our ecosystems and the sustainability of biological resources. This publication is an outcome of a detailed study conducted by the ICAR-Central Marine Fisheries Research Institute in collaboration with the Kerala State Biodiversity Board to document the rich biodiversity of the Kadalundi-Vallikunnu Community Reserve and to assess the economic value of the various ecosystem services rendered by the Community Reserve. The publication provides an insight in to the diversity of plankton, seagrass, mangroves, mangrove associates, avian fauna, molluscs, crustaceans and finfishes of the Community Reserve with an overview of the economic value of the ecosystem services. The various threats faced by the Community Reserve and meaningful options for the conservation and sustainable management of the Reserve is also highlighted in this document

Анализ причин производственного травматизма в организации

Статья посвящена вопросам исследования и снижения производственного травматизма в России. В статье раскрывается проблема производственного травматизма. Приведена статистика производственного травматизма в Российской Федерации. Представлены результаты общероссийского мониторинга, показана динамика производственного травматизма.The article is devoted to the issues of research and reducing industrial injuries in Russia. The article reveals the problem of occupational injuries. The statistics of occupational injuries in the Russian Federation. The results of the all-Russian monitoring are presented, the dynamics of industrial injuries are shown

Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies

Congenital insensitivity to pain (CIP) and hereditary sensory and autonomic neuropathies (HSAN) are clinically and genetically heterogeneous disorders exclusively or predominantly affecting the sensory and autonomic neurons. Due to the rarity of the diseases and findings based mainly on single case reports or small case series, knowledge about these disorders is limited. Here, we describe the molecular workup of a large international cohort of CIP/HSAN patients including patients from normally under-represented countries. We identify 80 previously unreported pathogenic or likely pathogenic variants in a total of 73 families in the >20 known CIP/HSAN-associated genes. The data expand the spectrum of disease-relevant alterations in CIP/HSAN, including novel variants in previously rarely recognized entities such as ATL3-, FLVCR1- and NGF-associated neuropathies and previously under-recognized mutation types such as larger deletions. In silico predictions, heterologous expression studies, segregation analyses and metabolic tests helped to overcome limitations of current variant classification schemes that often fail to categorize a variant as disease-related or benign. The study sheds light on the genetic causes and disease-relevant changes within individual genes in CIP/HSAN. This is becoming increasingly important with emerging clinical trials investigating subtype or gene-specific treatment strategies